CanSino Biologics Inc. (CASBF) Financials
CASBF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| Sept. 30, 2025 | 1.0 billion | 332.7 million |
| June 30, 2025 | 1.1 billion | 391.1 million |
| March 31, 2025 | 1.1 billion | 402.2 million |
CASBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| Sept. 30, 2025 | -2.1 million | ? |
| June 30, 2025 | -5.9 million | 77443 |
| March 31, 2025 | -11.2 million | ? |
CASBF Net Income
No data available :(
CASBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | - | - | - |
| Sept. 30, 2025 | 346.4 million | 147.6 million | 1.2 million |
| June 30, 2025 | 452.9 million | 120.7 million | 2.3 million |
| March 31, 2025 | 425.2 million | 153.5 million | 1.5 million |
CASBF Shares Outstanding
CASBF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | - | - | - |
| Sept. 30, 2025 | 6.5 million | 10.8 million | 22.1 million | - |
| June 30, 2025 | 9.4 million | 10.5 million | 19.3 million | 13.6 million |
| March 31, 2025 | 9.3 million | 10.0 million | 14.1 million | 8.1 million |
CASBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 52.9 million | - |
| Sept. 30, 2025 | 43.5 million | 9.4 million |
| June 30, 2025 | 34.2 million | 7.6 million |
| March 31, 2025 | 18.9 million | 3.3 million |
CASBF
Price: $3
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.10 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.3 billion